Influence of IL-1β on Pain and Inflammatory Response after Placement of a Cement-screw-retained Restoration

Florian Schedle^*
*Correspondence: Florian Schedle, Department of Stomatology, University of Seville, 41009 Seville, Spain, Email:

Keywords

Interleukin-1β • Inflammation • Cement–screw-retained restorations

Introduction

The placement of cement–screw-retained restorations is a common procedure in restorative dentistry. While these restorations offer several advantages, such as improved esthetics and retention, they can also elicit inflammatory responses post-placement. Interleukin-1β (IL-1β), a potent proinflammatory cytokine, has been implicated in various inflammatory conditions, including those related to dental procedures. Its involvement in pain modulation further underscores its significance in the context of postoperative discomfort after dental interventions [1].

Literature Review

IL-1β is primarily produced by activated macrophages and plays a crucial role in the initiation and propagation of inflammatory responses. Upon activation, IL-1β binds to its receptors, triggering downstream signaling pathways that culminate in the expression of inflammatory mediators and recruitment of immune cells. Additionally, IL-1β contributes to neuroinflammation and sensitization of nociceptive pathways, thereby modulating pain perception. Its multifaceted role in inflammation makes IL-1β a potential target for therapeutic interventions aimed at mitigating postoperative discomfort [2].

Pain is a complex phenomenon influenced by various factors, including inflammatory mediators like IL-1β. Studies have shown that elevated levels of IL-1β correlate with increased pain intensity and duration in several conditions, including postoperative pain following dental procedures. IL-1β acts directly on nociceptive neurons, sensitizing them to mechanical and chemical stimuli, thereby amplifying pain perception. Moreover, IL-1β can induce central sensitization, leading to heightened pain sensitivity and persistent discomfort. Understanding the role of IL-1β in pain modulation is essential for implementing strategies to manage postoperative pain effectively [3].

Discussion

Recent research has focused on investigating IL-1β levels in patients undergoing cement–screw-retained restoration procedures and their association with postoperative pain and inflammation. Studies utilizing techniques such as Enzyme-Linked Immunosorbent Assay (ELISA) and Polymerase Chain Reaction (PCR) have demonstrated elevated IL-1β levels in peri-implant tissues following restoration placement. Furthermore, a positive correlation has been observed between IL-1β concentrations and the severity of postoperative pain and inflammation. These findings highlight the potential role of IL-1β as a biomarker for assessing inflammatory response and predicting treatment outcomes in dental implant procedures [4].

The quantification of IL-1β levels in patients undergoing cement–screwretained restoration procedures provides valuable insights into the underlying inflammatory mechanisms and their impact on postoperative outcomes. Incorporating IL-1β assessment into routine clinical practice may facilitate early detection of excessive inflammation and aid in personalized treatment planning. Additionally, targeting IL-1β signaling pathways pharmacologically or through adjunctive therapies could mitigate postoperative pain and promote faster healing. Further research is warranted to elucidate the precise mechanisms linking IL-1β to pain and inflammation in the context of dental procedures and to explore novel therapeutic interventions targeting IL-1β for improved patient care [5,6].

Conclusion

IL-1β plays a pivotal role in mediating pain and inflammatory responses following placement of cement–screw-retained restorations in dental implant procedures. Quantification of IL-1β levels provides valuable insights into the underlying pathophysiology and can aid in predicting postoperative outcomes. Strategies aimed at modulating IL-1β signaling pathways hold promise for alleviating postoperative discomfort and enhancing treatment efficacy. Future research efforts should focus on elucidating the mechanisms underlying IL-1β- mediated inflammation and exploring novel therapeutic interventions targeting IL-1β for improved patient care in restorative dentistry.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Gomez‐Meda, Ramon, Jonathan Esquivel and Markus B. Blatz. "The esthetic biological contour concept for implant restoration emergence profile design." J Esthet Restor Dent 33 (2021): 173-184.

   Google Scholar, Crossref

2. Tomasi, Cristiano, Francesco Tessarolo, Iole Caola and Jan Wennström, et al. "Morphogenesis of peri‐implant mucosa revisited: An experimental study in humans." Clin Oral Implants Res 25 (2014): 997-1003.

   Google Scholar, Crossref

3. Kan, Joseph YK, Kitichai Rungcharassaeng, Kiyotaka Umezu and John C. Kois. "Dimensions of peri‐implant mucosa: An evaluation of maxillary anterior single implants in humans." J Periodontol 74 (2003): 557-562.

   Google Scholar, Crossref

4. Berglundh, Tord, J. Lindhe, I. Ericsson and C. P. Marinello, et al. "The soft tissue barrier at implants and teeth." Clin Oral Implants Res 2 (1991): 81-90.

   Google Scholar, Crossref, Indexed at

5. Buser, Daniel, Hans Peter Weber, Karl Donath and Joseph P. Fiorellini, et al. "Soft tissue reactions to non‐submerged unloaded titanium implants in beagle dogs." J Periodontol 63 (1992): 225-235.

   Google Scholar, Crossref, Indexed at

6. Abrahamsson, I., T. Berglundh, J. Wennström and J. Lindhe. "The peri‐implant hard and soft tissues at different implant systems. A comparative study in the dog." Clin Oral Implants Res 7 (1996): 212-219.

   Google Scholar, Crossref